E2209926

Anti-VEGF [Bevacizumab]

Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Ask for quotation

MBS488265-02mg

Anti-VEGF [Bevacizumab]

856.48 €

MBS488265-5x02mg

Anti-VEGF [Bevacizumab]

2968.39 €

E24CHA099

Anti-VEGFA Reference Antibody (bevacizumab)

Available in various conjugation types.

492.38 €

ICH4003B-0.1mg

Bevacizumab Biosimilar - Research Grade: Biotin

353.50 €

ICH4003HRP-0.1mg

Bevacizumab Biosimilar - Research Grade: HRP

353.50 €